CF
RLAY icon

CNA Financial’s Relay Therapeutics RLAY Stock Holding History

CNA Financial’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,499
Closed -$235K – 145
2022
Q3 		$235K Sell
10,499
-5,250
-33% -$115K 0.09% 156
2022
Q2 		$264K Buy
15,749
+200
+1% +$4.29K 0.09% 160
2022
Q1 		$465K Sell
15,549
-440
-3% -$10.7K 0.14% 154
2021
Q4 		$491K Buy
15,989
+3,190
+25% +$101K 0.13% 158
2021
Q3 		$404K Buy
12,799
+890
+7% +$30K 0.11% 173
2021
Q2 		$436K Buy
11,909
+1,060
+10% +$34.9K 0.12% 173
2021
Q1 		$375K Buy
10,849
+2,633
+32% +$114K 0.12% 176
2020
Q4 		$341K Buy
8,216
+1,420
+21% +$64.2K 0.11% 180
2020
Q3 		$289K Buy
+6,796
New +$259K 0.11% 170

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CNA Financial's RLAY Position: Q4 2022 in Review

CNA Financial sold out of Relay Therapeutics (RLAY) in Q4 2022, closing a stake of 10,499 shares — an estimated $235K sold.

CNA Financial first reported a position in RLAY in Q3 2020 and held it in 9 quarters. The position peaked at $491K in Q4 2021. 165 funds tracked by Wall St. Rank hold RLAY as of Q4 2022.

  • CNA Financial reported no remaining Relay Therapeutics position as of Q4 2022 after selling out during the quarter.
  • CNA Financial sold 10,499 Relay Therapeutics shares in Q4 2022, an estimated $235K.
  • CNA Financial first reported a position in Relay Therapeutics in Q3 2020 and held it in 9 quarters.
  • CNA Financial's Relay Therapeutics position peaked at $491K in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2022.

Based on CNA Financial's 13F filing for Q4 2022, filed 10 Feb 2023.